Relationship between standardized uptake value on 18F-FDG PET and PD-L1 expression in clear cell renal cell carcinoma

PURPOSE: Partial clear cell renal cell carcinoma (CCRCC) may be sensitive to immune checkpoint inhibitor treatment targeting the programmed cell death 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) pathway. Assessing the levels of PD-L1 using non-invasive imaging is useful to select immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Huo, Yanlei, Ma, Chao, Lv, Zhongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577457/
https://www.ncbi.nlm.nih.gov/pubmed/36267974
http://dx.doi.org/10.3389/fonc.2022.1012561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577457/
https://www.ncbi.nlm.nih.gov/pubmed/36267974
http://dx.doi.org/10.3389/fonc.2022.1012561

Ejemplares similares